Article Details
Retrieved on: 2024-08-01 18:16:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
RedHill Biopharma (RDHL) stock is up more than 75% on a key announcement released today. · The company reported positive Phase 3 clinical trial results ...
Article found on: investorplace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here